Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Use of nonsteroidal anti-inflammatory drugs and survival following breast cancer diagnosis.

Li Y, Brasky TM, Nie J, Ambrosone CB, McCann SE, Shields PG, Trevisan M, Edge SB, Freudenheim JL.

Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):239-42. doi: 10.1158/1055-9965.EPI-11-1012. Epub 2011 Nov 8.

2.

Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study.

Gierach GL, Lacey JV Jr, Schatzkin A, Leitzmann MF, Richesson D, Hollenbeck AR, Brinton LA.

Breast Cancer Res. 2008;10(2):R38. doi: 10.1186/bcr2089. Epub 2008 Apr 30.

3.

Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.

Marshall SF, Bernstein L, Anton-Culver H, Deapen D, Horn-Ross PL, Mohrenweiser H, Peel D, Pinder R, Purdie DM, Reynolds P, Stram D, West D, Wright WE, Ziogas A, Ross RK.

J Natl Cancer Inst. 2005 Jun 1;97(11):805-12.

PMID:
15928301
4.

NSAID use and survival after breast cancer diagnosis in post-menopausal women.

Blair CK, Sweeney C, Anderson KE, Folsom AR.

Breast Cancer Res Treat. 2007 Jan;101(2):191-7. Epub 2006 Jul 6.

PMID:
16823508
5.

Lifetime use of nonsteroidal anti-inflammatory drugs and breast cancer risk: results from a prospective study of women with a sister with breast cancer.

Kim S, Shore DL, Wilson LE, Sanniez EI, Kim JH, Taylor JA, Sandler DP.

BMC Cancer. 2015 Dec 16;15:960. doi: 10.1186/s12885-015-1979-1.

6.

Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort.

Jacobs EJ, Thun MJ, Connell CJ, Rodriguez C, Henley SJ, Feigelson HS, Patel AV, Flanders WD, Calle EE.

Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):261-4.

7.

Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative.

Harris RE, Chlebowski RT, Jackson RD, Frid DJ, Ascenseo JL, Anderson G, Loar A, Rodabough RJ, White E, McTiernan A; Women's Health Initiative.

Cancer Res. 2003 Sep 15;63(18):6096-101.

8.

Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and risk of breast cancer among premenopausal women in the Nurses' Health Study II.

Eliassen AH, Chen WY, Spiegelman D, Willett WC, Hunter DJ, Hankinson SE.

Arch Intern Med. 2009 Jan 26;169(2):115-21; discussion 121. doi: 10.1001/archinternmed.2008.537.

9.

Aspirin and nonsteroidal anti-inflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: a meta-analysis.

Huang XZ, Gao P, Sun JX, Song YX, Tsai CC, Liu J, Chen XW, Chen P, Xu HM, Wang ZN.

Cancer Causes Control. 2015 Apr;26(4):589-600. doi: 10.1007/s10552-015-0539-y. Epub 2015 Feb 21.

PMID:
25701248
10.

Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer.

Coghill AE, Newcomb PA, Campbell PT, Burnett-Hartman AN, Adams SV, Poole EM, Potter JD, Ulrich CM.

Gut. 2011 Apr;60(4):491-8. doi: 10.1136/gut.2010.221143. Epub 2010 Nov 4.

11.

Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study.

Brasky TM, Bonner MR, Moysich KB, Ambrosone CB, Nie J, Tao MH, Edge SB, Kallakury BV, Marian C, Trevisan M, Shields PG, Freudenheim JL.

Cancer Causes Control. 2010 Sep;21(9):1503-12. doi: 10.1007/s10552-010-9579-5. Epub 2010 May 25.

12.

Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk.

Terry MB, Gammon MD, Zhang FF, Tawfik H, Teitelbaum SL, Britton JA, Subbaramaiah K, Dannenberg AJ, Neugut AI.

JAMA. 2004 May 26;291(20):2433-40.

PMID:
15161893
13.

Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality.

Bardia A, Ebbert JO, Vierkant RA, Limburg PJ, Anderson K, Wang AH, Olson JE, Vachon CM, Cerhan JR.

J Natl Cancer Inst. 2007 Jun 6;99(11):881-9.

PMID:
17551148
14.

Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer.

Rahme E, Ghosn J, Dasgupta K, Rajan R, Hudson M.

BMC Cancer. 2005 Dec 12;5:159.

15.

Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, acetaminophen and ovarian cancer survival.

Nagle CM, Ibiebele TI, DeFazio A, Protani MM, Webb PM; Australian Ovarian Cancer Study Group.

Cancer Epidemiol. 2015 Apr;39(2):196-9. doi: 10.1016/j.canep.2014.12.010. Epub 2015 Feb 7.

PMID:
25666512
16.

Regular aspirin use and breast cancer risk in US Black women.

Bosco JL, Palmer JR, Boggs DA, Hatch EE, Rosenberg L.

Cancer Causes Control. 2011 Nov;22(11):1553-61. doi: 10.1007/s10552-011-9832-6. Epub 2011 Aug 30.

17.

Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis.

Takkouche B, Regueira-Méndez C, Etminan M.

J Natl Cancer Inst. 2008 Oct 15;100(20):1439-47. doi: 10.1093/jnci/djn324. Epub 2008 Oct 7.

PMID:
18840819
18.

Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence.

Zhang X, Smith-Warner SA, Collins LC, Rosner B, Willett WC, Hankinson SE.

J Clin Oncol. 2012 Oct 1;30(28):3468-77. Epub 2012 Aug 27.

19.

Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer.

Johnson TW, Anderson KE, Lazovich D, Folsom AR.

Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1586-91.

20.

Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study.

Bardia A, Olson JE, Vachon CM, Lazovich D, Vierkant RA, Wang AH, Limburg PJ, Anderson KE, Cerhan JR.

Breast Cancer Res Treat. 2011 Feb;126(1):149-55. doi: 10.1007/s10549-010-1074-x. Epub 2010 Jul 29.

Supplemental Content

Support Center